7OPAM50MET: A prognostic model based on PAM50 and clinical variables in metastatic hormone receptor (HR)-positive/HER2 negative breast cancer. (13th May 2019) - Prat, A; Tsai, Y-H; Pascual, T; Paré, L; Vidal, M; Adamo, B; Brase, J C; Johnston, S R D; Ciruelos, E M; Parker, J S